P3 Health Partners Officially Regains Nasdaq Listing Compliance
PIII has more than doubled off its 52-week low of $1.52 on light trading volume (0.2× avg).
Summary
P3 Health Partners Inc. announced it has received official notification from Nasdaq that it has regained compliance with the exchange's continued listing requirements, resolving a prior delisting threat.
Key Events · Corporate Governance and Compliance · PIII
-
Nasdaq Compliance Confirmed
The company received a letter from Nasdaq on May 20, 2026, officially notifying it that it has returned to compliance with Nasdaq Listing Rule 5550(b)(2).
-
Resolution of Delisting Threat
This resolves the previously disclosed non-compliance issues and the associated risk of delisting from The Nasdaq Stock Market LLC.
-
Follows Recent Financial Improvements
The compliance determination is based on the company's Form 8-K filed on May 15, 2026, which likely referenced the strong Q1 2026 financial results, including positive net income and Adjusted EBITDA.
Analysis · PIII · Industrial Applications And Services
This filing confirms that Nasdaq has officially determined P3 Health Partners Inc. is back in compliance with its listing rules. This removes a significant overhang and delisting risk that the company had been facing, as previously disclosed with a going concern warning and Nasdaq non-compliance notice. Regaining compliance is a critical step for investor confidence and market stability, validating the company's recent financial improvements, including its first-ever positive net income and Adjusted EBITDA for Q1 2026.
At the time of this filing, PIII was trading at $12.99 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $94.1M. The 52-week trading range was $1.52 to $14.89. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.